drugset / Trial / NCT04888715
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An open label, 2-part, one-sequence, 3-period study to evaluate drug-drug interactions between DWN12088 and Pirfenidone or Nintedanib in healthy volunteers
Timeline
- Start
- 2021-07-23
- Primary completion
- 2021-08-02
- Completion
- 2021-08-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BERSIPOROCIN | Small molecule | — | Oral |
| Subject | Nintedanib | Small molecule | — | Oral |
| Subject | Pirfenidone | Small molecule | — | Oral |